Development of microemulsion of tamsulosin and dutasteride for benign prostatic hyperplasia therapy-Reference-Cited by-同舟云学术

Development of microemulsion of tamsulosin and dutasteride for benign prostatic hyperplasia therapy

Published:2020-01 Issue: Volume:185 Page:110573
ISSN:0927-7765
Container-title:Colloids and Surfaces B: Biointerfaces
language:en
Short-container-title:Colloids and Surfaces B: Biointerfaces

Author:

Ciríaco Shayara Lopes,Carvalho Ivana Pereira Santos^ORCID,Alves Terceiro Neto José,de Sousa Lima Neto José,de Oliveira Daniel Henrique Bento,Cunha Ana Paula Gomes Pereira,Cavalcante Ykro Talvanis Duarte,da Silva Dayane Tomaz Casimiro^ORCID,da Silva José Alexsandro,Mineiro Ana Lys Bezerra Barradas,de Lima Chagas Moreno Fernandes Maria Zenaide,Carvalho André Luis Menezes

Funder

CAPES

Laboratory of the Federal University of Piauí - Brazil

CETENE

Publisher

Elsevier BV

Subject

Colloid and Surface Chemistry,Physical and Theoretical Chemistry,Surfaces and Interfaces,General Medicine,Biotechnology

Reference66 articles.

1. Benign Prostatic Hyperplasia and lower urinary tract symptoms guidelines;Roehrborn;N. Engl. J. Med.,2012

2. Benign prostatic hyperplasia;Paolone;Clin. Geriatr. Med.,2010

3. Improved oral absorption of dutasteride via Soluplus®-based supersaturable self-emulsifying drug delivery system (S-SEDDS);Lee;Int. J. Pharm.,2015